Women treated with antimuscarinics for overactive bladder syndrome are more likely to be diagnosed with depression after treatment onset than overactive bladder patients not treated with the ...

Standard stepwise therapy for overactive bladder (OAB) begins with conservative therapies such as lifestyle interventions and behavioral approaches. Medications—anticholinergics or beta-3 agonists—are ...

The American Urologic Association advises caution in the use of anticholinergic medications to treat older or frail adults with OAB. Despite an increased risk of cognitive decline associated with ...

A new study suggests that more women are being prescribed beta-3 agonists over anticholinergics for the treatment of overactive bladder (OAB), suggesting that more clinicians may be choosing this ...

Results are from a meta-analysis of 33 trials involving 35,939 patients with overactive bladder. Overactive bladder treatment using antimuscarinic drugs increases the risks for urinary tract infection ...

—Maybe, say the results of a UK meta-analysis, which found some patients to benefit from the alternative approach. Considering the side effects of certain OAB medications and poor adherence, it’s ...

OAB is commonly treated with a class of medicines called anticholinergics or antimuscarinics. These medicines block chemicals in your body that help the bladder to squeeze. By blocking these chemicals ...

If frequent bathroom trips disrupt your life, you are not alone. Women's health expert Kirtly Jones, MD, talks to urogynecologist Whitney Hendrickson, MD, about the complexities of overactive bladder ...

Approximately 33% of American women will experience overactive bladder syndrome (OAB), which interferes with daily activities, social functioning, and sleep quality. There have been few studies ...